Showing results (401-410 of 486) with videos related to

Sort By:
Pageof 49
Cell Reports|March 12, 2020
ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative NeoplasmsManon Viaud, Omar Abdel-Wahab, Julie Gall, et al.
Cancer Research|February 11, 2010
miR-181a and miR-630 regulate cisplatin-induced cancer cell deathLorenzo Galluzzi, Eugenia Morselli, Ilio Vitale, et al.
Cell Reports|April 14, 2021
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patientsGiampaolo Morciano, Gaia Pedriali, Massimo Bonora, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphomaMohammad Alhomoud, Michelle Foley, Mayumi Sugita, et al.
The EMBO Journal|February 27, 2010
Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on MosIlio Vitale, Laura Senovilla, Mohamed Jemaà, et al.
Haematologica|October 5, 2019
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patientsIva Truxova, Lenka Kasikova, Cyril Salek, et al.
Cell Cycle (Georgetown, Tex.)|June 10, 2011
Hypomethylating agents reactivate FOXO3A in acute myeloid leukemiaSylvain Thépot, Elodie Lainey, Thomas Cluzeau, et al.
EMBO Molecular Medicine|March 23, 2012
Selective killing of p53-deficient cancer cells by SP600125Mohamed Jemaà, Ilio Vitale, Oliver Kepp, et al.
Pageof 49